HB 211 creates Louisiana's "Homelessness Court Program," establishing specialized court divisions to address homelessness through treatment and support instead of incarceration. It directly affects individuals experiencing homelessness charged with misdemeanors or felonies related to public camping or survival needs, requiring courts to screen eligible defendants for the program. Key provisions include mandatory substance abuse and mental health treatment, housing/job assistance partnerships, and a new criminal penalty for "unauthorized camping on public property" (with exceptions for shelter access). The program aims to reduce recidivism, court workloads, and prison overcrowding by integrating health care, housing, and rehabilitation services under judicial supervision.
HB 306 requires domestic violence perpetrators in Louisiana to pay all court costs, attorney fees, enforcement fees, evaluation fees, expert witness fees, and medical/psychological care costs for victims (adults or children) related to the abuse. This applies during the initial phase of domestic abuse cases, before the first hearing. After the initial hearing, standard civil rules apply, and each party covers their own attorney fees. The bill directly affects domestic violence victims (by reducing their financial burden) and perpetrators (by shifting cost responsibility to them).
HB 181 authorizes the Louisiana Department of Revenue to share state income tax return data with the legislative auditor exclusively to improve Medicaid program integrity. It specifically permits this data sharing to verify Medicaid eligibility accuracy, detect fraud, and comply with existing Medicaid fraud laws. The bill restricts the use of this data to these three purposes only and requires formal agreements between agencies for data sharing. This affects Medicaid program participants and administrators by enabling targeted fraud prevention through cross-agency data access.
SB 84 requires all health insurance plans sold in Louisiana to cover prostate cancer screening for men aged 40-49 (as medically appropriate) and men over 50, following National Comprehensive Cancer Network guidelines. It mandates that insurers cover these screenings without any out-of-pocket costs for enrollees, including deductibles, copays, or coinsurance. The law applies to new policies starting January 1, 2027, and existing policies must comply by January 1, 2028. This directly affects Louisiana health insurers and their policyholders by guaranteeing no-cost access to recommended prostate cancer screenings.
SB 181 exempts nonprofit healthcare organizations in Louisiana from needing a state license to hold charitable games of chance (like raffles or bingo). Instead, these organizations must annually notify the Office of Charitable Gaming of their participation. The bill defines "nonprofit healthcare organization" broadly to include healthcare providers, their parent organizations, affiliates, and foundations that are tax-exempt and licensed in Louisiana. This change directly affects eligible healthcare groups, allowing them to operate games without a license while maintaining reporting requirements.
SB 190 requires Louisiana nursing homes identified by federal authorities as candidates for the Centers for Medicare and Medicaid Services' "Special Focus Facility Program" (due to persistent safety issues like abuse or health risks) to undergo enhanced state oversight. It mandates facilities to notify residents about safety concerns, offer transfer options, and comply with stricter state requirements - including quarterly unannounced inspections, root cause analyses, and staffing adjustments. If a facility fails to meet these requirements within 18 months, the state can revoke its license. The bill also prohibits repeat participation in the program, requiring license revocation or facility closure for repeat offenders.
HB 656 establishes a pilot program to provide structured programming to specific inmates in Louisiana. It directly affects juvenile offenders and inmates held in parish jails or prisons under the Department of Public Safety and Corrections (DPS&C). The program must include rehabilitation services (education/vocational training), mental health support, and suicide prevention initiatives. Programming will be delivered in-person or via video for accessibility, with DPS&C required to create implementing rules. This bill focuses on expanding access to support services within correctional facilities.
HB 395 requires Louisiana's Department of Education to create a program recruiting, hiring, and retaining mental health professionals - including counselors, social workers, school psychologists, and behavioral health specialists - in public elementary and secondary schools. The bill mandates the department to aim for a ratio of one mental health professional per 250 students across all public schools. Implementation depends on future legislative funding, as Section 2 states the program becomes effective only after a specific appropriation is approved. This directly affects Louisiana's public schools and their ability to support student mental health needs through staff expansion.
HB 833 creates the Sexual Assault Survivor Empowerment Task Force in Louisiana to study and recommend improvements to services for sexual assault survivors. The task force, composed of members from the attorney general's office, sheriffs' association, state legislators, and district attorneys, will evaluate needs like counseling, school/work accommodations, and mandatory training for schools/hospitals/law enforcement. It must submit a report with specific recommendations to the governor and legislature by February 1, 2027, after which the task force will terminate. This bill does not change existing laws but sets up a process to inform future legislation.
HB 870 requires Louisiana health insurance issuers to immediately place cheaper generic drugs and biosimilars on more favorable formulary tiers (with lower out-of-pocket costs) when their wholesale acquisition cost is lower than the brand-name reference drug or product. Specifically, if a generic drug costs less than its brand-name equivalent at launch, insurers must cover it with better cost-sharing and cannot impose prior authorization, step therapy, or pharmacy restrictions that make it harder to access than the brand. The same rules apply to biosimilars that are cheaper than their reference biological products. This directly affects health insurance plans and enrollees seeking coverage for these cost-effective alternatives. The bill aims to reduce patient costs by mandating insurer action when cheaper, equivalent options become available.
